title: Herpes simplex virus type 2 glycoprotein H interacts with integrin αvβ3 to facilitate viral entry and calcium signaling in human genital tract epithelial cells.
abstract: Herpes simplex virus (HSV) entry requires multiple interactions at the cell surface and activation of a complex calcium signaling cascade. Previous studies demonstrated that integrins participate in this process, but their precise role has not been determined. These studies were designed to test the hypothesis that integrin αvβ3 signaling promotes the release of intracellular calcium (Ca2+) stores and contributes to viral entry and cell-to-cell spread. Transfection of cells with small interfering RNA (siRNA) targeting integrin αvβ3, but not other integrin subunits, or treatment with cilengitide, an Arg-Gly-Asp (RGD) mimetic, impaired HSV-induced Ca2+ release, viral entry, plaque formation, and cell-to-cell spread of HSV-1 and HSV-2 in human cervical and primary genital tract epithelial cells. Coimmunoprecipitation studies and proximity ligation assays indicated that integrin αvβ3 interacts with glycoprotein H (gH). An HSV-2 gH-null virus was engineered to further assess the role of gH in the virus-induced signaling cascade. The gH-2-null virus bound to cells and activated Akt to induce a small Ca2+ response at the plasma membrane, but it failed to trigger the release of cytoplasmic Ca2+ stores and was impaired for entry and cell-to-cell spread. Silencing of integrin αvβ3 and deletion of gH prevented phosphorylation of focal adhesion kinase (FAK) and the transport of viral capsids to the nuclear pore. Together, these findings demonstrate that integrin signaling is activated downstream of virus-induced Akt signaling and facilitates viral entry through interactions with gH by activating the release of intracellular Ca2+ and FAK phosphorylation. These findings suggest a new target for HSV treatment and suppression.
  
  
  OBJECTIVE
  Herpes simplex viruses are the leading cause of genital disease worldwide, the most common infection associated with neonatal encephalitis, and a major cofactor for HIV acquisition and transmission. There is no effective vaccine. These epidemiological findings underscore the urgency to develop novel HSV treatment or prevention strategies. This study addresses this gap by further defining the signaling pathways the virus usurps to enter human genital tract epithelial cells. Specifically, the study defines the role played by integrins and by the viral envelope glycoprotein H in entry and cell-to-cell spread. This knowledge will facilitate the identification of new targets for the development of treatment and prevention.
authors.affiliation: Department of Pediatrics, Albert Einstein College of Medicine, Bronx, New York, USA.
authors.forename: Natalia
authors.initials: N
authors.lastname: Cheshenko
authors.affiliation: Department of Pediatrics, Albert Einstein College of Medicine, Bronx, New York, USA Department of Microbiology-Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
authors.forename: Janie B
authors.initials: JB
authors.lastname: Trepanier
authors.affiliation: Department of Microbiology-Immunology, Albert Einstein College of Medicine, Bronx, New York, USA Millennium Institute on Immunology and Immunotherapy, Pontificia Universidad Católica de Chile, Santiago, Chile.
authors.forename: Pablo A
authors.initials: PA
authors.lastname: González
authors.affiliation: Department of Microbiology-Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
authors.forename: Eliseo A
authors.initials: EA
authors.lastname: Eugenin
authors.affiliation: Department of Microbiology-Immunology, Albert Einstein College of Medicine, Bronx, New York, USA Department of Genetics, Albert Einstein College of Medicine, Bronx, New York, USA Howard Hughes Medical Institute, Albert Einstein College of Medicine, Bronx, New York, USA.
authors.forename: William R
authors.initials: WR
authors.lastname: Jacobs
authors.affiliation: Department of Pediatrics, Albert Einstein College of Medicine, Bronx, New York, USA Department of Microbiology-Immunology, Albert Einstein College of Medicine, Bronx, New York, USA betsy.herold@einstein.yu.edu.
authors.forename: Betsy C
authors.initials: BC
authors.lastname: Herold
mesh_terms: D020013:Calcium Signaling; D002478:Cells, Cultured; D004847:Epithelial Cells / Q000502:physiology / Q000821:virology*; D005260:Female; D017353:Gene Deletion; D055785:Gene Knockdown Techniques; D018258:Herpesvirus 2, Human / Q000235:genetics / Q000502:physiology*; D054884:Host-Pathogen Interactions; D006801:Humans; D039302:Integrin alphaVbeta3 / Q000378:metabolism*; D011485:Protein Binding; D025941:Protein Interaction Mapping; D014759:Viral Envelope Proteins / Q000235:genetics / Q000378:metabolism*; D053586:Virus Internalization
chemical_list: D039302:Integrin alphaVbeta3; D014759:Viral Envelope Proteins